Your browser doesn't support javascript.
loading
AI-enhanced Mammography With Digital Breast Tomosynthesis for Breast Cancer Detection: Clinical Value and Comparison With Human Performance.
Resch, Daphne; Lo Gullo, Roberto; Teuwen, Jonas; Semturs, Friedrich; Hummel, Johann; Resch, Alexandra; Pinker, Katja.
Affiliation
  • Resch D; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Lo Gullo R; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Teuwen J; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Semturs F; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Hummel J; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Resch A; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
  • Pinker K; From the Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria (D.R.); Department of Radiology, Breast Imaging Service, Memorial Sloan-Kettering Cancer Center, New York, NY (R.L.G., J.T.); Center for Medical Physics
Radiol Imaging Cancer ; 6(4): e230149, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38995172
ABSTRACT
Purpose To compare two deep learning-based commercially available artificial intelligence (AI) systems for mammography with digital breast tomosynthesis (DBT) and benchmark them against the performance of radiologists. Materials and Methods This retrospective study included consecutive asymptomatic patients who underwent mammography with DBT (2019-2020). Two AI systems (Transpara 1.7.0 and ProFound AI 3.0) were used to evaluate the DBT examinations. The systems were compared using receiver operating characteristic (ROC) analysis to calculate the area under the ROC curve (AUC) for detecting malignancy overall and within subgroups based on mammographic breast density. Breast Imaging Reporting and Data System results obtained from standard-of-care human double-reading were compared against AI results with use of the DeLong test. Results Of 419 female patients (median age, 60 years [IQR, 52-70 years]) included, 58 had histologically proven breast cancer. The AUC was 0.86 (95% CI 0.85, 0.91), 0.93 (95% CI 0.90, 0.95), and 0.98 (95% CI 0.96, 0.99) for Transpara, ProFound AI, and human double-reading, respectively. For Transpara, a rule-out criterion of score 7 or lower yielded 100% (95% CI 94.2, 100.0) sensitivity and 60.9% (95% CI 55.7, 66.0) specificity. The rule-in criterion of higher than score 9 yielded 96.6% sensitivity (95% CI 88.1, 99.6) and 78.1% specificity (95% CI 73.8, 82.5). For ProFound AI, a rule-out criterion of lower than score 51 yielded 100% sensitivity (95% CI 93.8, 100) and 67.0% specificity (95% CI 62.2, 72.1). The rule-in criterion of higher than score 69 yielded 93.1% (95% CI 83.3, 98.1) sensitivity and 82.0% (95% CI 77.9, 86.1) specificity. Conclusion Both AI systems showed high performance in breast cancer detection but lower performance compared with human double-reading. Keywords Mammography, Breast, Oncology, Artificial Intelligence, Deep Learning, Digital Breast Tomosynthesis © RSNA, 2024.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Artificial Intelligence / Mammography Limits: Aged / Female / Humans / Middle aged Language: En Journal: Radiol Imaging Cancer Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Artificial Intelligence / Mammography Limits: Aged / Female / Humans / Middle aged Language: En Journal: Radiol Imaging Cancer Year: 2024 Document type: Article